text.skipToContent text.skipToNavigation

Maximum quantity allowed is 999

Please select the quantity

CAS RN: 58306-30-2 | Product Number: F0922

Febantel


Purity:
Synonyms:
Documents:
1G
€73.00
1   2  
5G
€234.00
1   ≥40 

*Stock available in Belgium will be delivered in 1 to 3 days
*Stock available in Japan will be delivered in 1 to 2 weeks (excludes regulated items and dry ice shipments).


Product Number F0922
Molecular Formula / Molecular Weight C__2__0H__2__2N__4O__6S = 446.48 
Physical State (20 deg.C) Solid
CAS RN 58306-30-2
Reaxys Registry Number 13258677
PubChem Substance ID 253661507
Merck Index (14) 3944
MDL Number

MFCD01738527

Specifications
Appearance White to Almost white powder to crystal
Purity(HPLC) min. 98.0 area%
Purity(with Total Nitrogen) min. 98.0 %
Melting point 125.0 to 129.0 °C
Properties (reference)
Melting Point 130 °C
Solubility in water Insoluble
GHS
Related Laws:
EC Number 261-205-0
RTECS# FB3955000
Transport Information:
HS Number 2930909899
Application
Febantel: A Broad-Spectrum Pro-Benzimidazole Anthelminthic

Febantel is a veterinary anthelmintic belonging to the chemical class of the benzimidazoles, but is a so-called pro-benzimidazole. Febantel itself has no anthelmintic properties. It is transformed into active fenbendazole and fenbendazole sulfoxide (= oxfendazole) in the host's liver. It is highly active against various species of nematodes and cestodes in mice, rats, dogs, sheep, and cattle. Recently, Febantel is often used in combination with other anthelmintics (pyrantel pamoate and etc.). (The product is for research purpose only.)

References


PubMed Literature


TCIMAIL
Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.

The requested SDS is not available.

Please Contact Us for more information.

Specifications
C of A & Other Certificates
Please enter Lot Number Incorrect Lot Number is entered
Analytical Charts
Please enter Lot Number Incorrect Lot Number is entered

The requested analytical chart is not available. Sorry for the inconvenience.

Other Documents